Episode 23 - Are Monoclonal Antibodies a Possible Treatment for Long COVID? With Professor Nancy Klimas

From Long COVID the Answers by Kojala Medical

December 7, 2024 · 21 min · Season 2 · Episode 23

About this episode

Dr Funmi Okunola interviews Professor Nancy Klimas about the potential of Monoclonal Antibodies as a treatment for Long COVID.

Dr Funmi Okunola MD interviews Professor Nancy Klimas MD about her research into the use of Monoclonal Antibodies as a possible treatment for Long COVID. We have an exciting and exclusive breaking news item in this episode! REFERENCES 1 Scheppke KA, Pepe PE, Jui J, Crowe RP, Scheppke EK, Klimas NG, Marty AM. Remission of severe forms of long COVID following monoclonal antibody (MCA) infusions: a report of signal index cases and call for targeted research. The American Journal of Emergency Medicine. 2024 Jan 1;75:122-7. 2 Zuo W, He D, Liang C, Du S, Hua Z, Nie Q, Zhou X, Yang M, Tan H, Xu J, Yu Y. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. The Lancet Infectious Diseases. 2024 Apr 22. 3 Hope & Help for Fatigue and Chronic Illness - The Institute For Neuro-Immune Medicine Podcast 4   Appelman B, Charlton BT, Goulding RP, Kerkhoff TJ, Breedveld EA, Noort W, Offringa C, Bloemers FW, van Weeghel M, Schomakers BV, Coelho P., Wüst Rob.C Muscle abnormalities worsen after post-exertional malaise in long COVID. Nature communications. 2024 Jan 4;15(1):1-5

People in this episode

Hosts: Dr Funmi Okunola MD, Dr Funmi Okunola

Guests: Professor Nancy Klimas MD, Professor Nancy Klimas

Topics covered

Monoclonal Antibodies
Long COVID
Medical Research
Treatment Options
Health Innovations

Keywords

Long COVID
Monoclonal Antibodies
treatment
Professor Nancy Klimas
medical research
COVID-19
healthcare

Mentioned in this episode

Organizations: The American Journal of Emergency Medicine, The Lancet Infectious Diseases, Nature communications, Institute For Neuro-Immune Medicine